RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
NIEHS Report on the in vivo repeat dose biological potency study of perfluorohexanesulfonamide (CASRN 41997-13-1) in Sprague Dawley (Hsd:Sprague Dawley® SD®) rats (Gavage Studies)
NIEHS Report 10
Auerbach, S., Ballin, J., Blake, J. C., Browning, D. B., Collins, B. J., Cora, M. C., Fernando, R., Fostel, J. M., Liu, Y., Luh, J., Machesky, N., Prince, L., Roberts, G. K., Shipkowski, K. A., Silinski, M. A. R., Skowronek, A., Sparrow, B., Toy, H., Waidyanatha, S., & Watson, A. (2023). NIEHS Report on the in vivo repeat dose biological potency study of perfluorohexanesulfonamide (CASRN 41997-13-1) in Sprague Dawley (Hsd:Sprague Dawley® SD®) rats (Gavage Studies): NIEHS Report 10. NIEHS Report Series. https://doi.org/10.22427/NIEHS-10